With an MD from Chicago Medical School, urologist Dr. Alan Sadah holds privileges at a number of Illinois hospitals, including St. Alexius Medical Center, Alexian Brothers Medical Center, and Westlake Hospital. In 2011 Dr. Alan Sadah assumed his current position as a medical doctor and urologist with Metro Chicago Surgical Oncology, LLC, where he treats a variety of medical issues such as frequent urination.
Frequent urination is listed as a symptom for a wide range of issues, from something as severe as kidney disease to something far more simple, like drinking excessive fluids. That said, individuals must first determine whether their urinary habits constitute frequent urination before consulting with a medical professional.
The average person urinates between six and eight times per day. However, a number of factors can influence these numbers. It would not be uncommon, for example, for an especially well-hydrated person to urinate as many as 10 times in a 24-hour period. Furthermore, certain medications, including diuretics for high blood pressure, count increased urination among their side effects.
Other aspects of urination should be treated with a similarly thorough analysis. For example, the average person can sleep between six and eight hours without waking up with the urge to urinate. Despite this fact, waking up once per night to pee should not be automatically viewed as cause for concern, particularly if a person drinks water or other liquids shortly before going to bed.
Individuals who feel they may be urinating too frequently should discuss their concerns and urinary habits with a urologist.
Treating patients at Metro Chicago Surgical Oncology, LLC, Dr. Alan Sadah is a urologist and surgeon with extensive experience treating prostate and bladder cancer. With privileges at half a dozen Chicago-area hospitals including Alexian Brothers Medical Center and Kindred Hospital, Dr. Alan Sadah has cared for patients with prostate and bladder cancer for more than two decades.
Usually affecting people older than 70, bladder cancer begins in the interior lining of the bladder. A cancer that is more prevalent in men, bladder cancer is most treatable when it’s caught early. People should always pay attention to the appearance of blood in the urine (one of the earliest signs of bladder cancer), even if just a tinge of blood is present.
In addition to blood in the urine, other signs that may indicate bladder cancer include burning, feelings of irritation or pain when urinating, difficulty urinating, pain in the bladder area, and the need to urinate frequently or urgently. Women and men who experience any of these symptoms should ask their doctor to perform a thorough evaluation of their urinary tract, including the kidneys and bladder, for signs of cancer or other ailments.
At Metro Chicago Surgical Oncology LLC, Dr. Alan Sadah provides urological care spanning a variety of procedures, including ultrasound and biopsies. Dr. Alan Sadah has extensive experience treating tumors, including through his work on staff at the Chicago Prostate Cancer Center.
Recent research at the University of York suggests new avenues for distinguishing manageable cancer from prostate cancer that requires surgery. For those with non-life-threatening forms of prostate disease, active monitoring can prove less expensive and result in a significantly lower number of negative side effects.
The research, which focuses on cancer type alterations, involves the comparison of hundreds of noncancerous tissue samples with cancerous samples. The scientists algorithmically eliminated genetic pattern noise among nearly a million markers, which left them with 17 distinct genetic markers associated with prostate cancer. This knowledge has the potential to result in fewer unnecessary surgeries and radiotherapy treatments, lessening the financial burden associated with prostate cancer surgery and making medical treatment more effective.
Since 2011, Dr. Alan Sadah has served as a urologist at Metro Chicago Surgical Oncology. Dr. Alan Sadah has practiced in his specialty for more than 25 years, during which time he has served numerous patients with prostate cancer and spoken extensively on the topic.
The prostate gland is a component of the male reproductive system. It produces and secretes prostate fluid, which serves as a carrier for semen during the ejaculation process.
When a man ejaculates, sperm travel from the testes through the vas deferens. These tubes carry the semen into the region of the prostate, which circumscribes the urethra underneath the bladder. The prostate then contracts, separating the bladder from the prostate, and releases fluid and semen into the urethra.
Older men are at increased risk of benign prostate hyperplasia (BPH), an enlargement of the prostate that causes a compression of the urethra and irritation of the bladder. This affects more than 60 percent of men in their 60s and 90 percent of men in their 70s and 80s.
Symptoms of BPH include a weak or interrupted urine stream, urinary leakage, or frequent urination. These symptoms of prostate growth may also indicate prostate cancer, which affected 200,000 men at the time the National Cancer Institute collected data in 2010.
A board-certified surgeon and urologist, Dr. Alan Sadah practices with Metro Chicago Surgical Oncology. Also on staff at Advocate Good Samaritan Hospital, Alexian Brothers Medical Center, Chicago Prostate Cancer Center, Gottlieb Memorial Hospital, Kindred Hospital, St. Alexius Medical Center, Westlake Hospital, and West Suburban Medical Center, Dr. Alan Sadah lectures and writes publications on numerous subjects, including incontinence.
Recently, a review of 14 previously published studies revealed that women who are overweight or obese have a greater risk of developing urinary incontinence. The review, performed by scientists at the University of Queensland, looked at more than 47,000 women in eight countries. The women had various subtypes of urinary incontinence, including urge, stress, mixed, and severe.
According to the results, the risk of urinary incontinence increased by a third in women who were overweight. As weight increased, the risk of incontinence also increased.
Among women who were obese, the risk of developing incontinence was two times higher than the risk of women with a “normal” body mass index. Weight was the only significant difference that researchers found.
Comparisons between women under the age of 35 and women between the ages of 36 and 55 showed no significant difference in risk of urinary incontinence. Further, researchers found no difference in risk for the different subtypes of urinary incontinence.
Serving the needs of patients at Metro Chicago Surgical Oncology, LLC, Dr. Alan Sadah is focused on urological care that includes ureteroscopy and renoscopy, as well as procedures such as biopsies and ultrasound. Dr. Alan Sadah is a member of the American Urological Association, which recently released guidelines designed to emphasize “nephron-sparing approaches” when addressing small renal masses through surgery.
With radical nephrectomy (RN) involving the complete removal of one kidney to treat cancer, a recent Johns Hopkins University study brought about the new more conservative recommendations. The study involved comparison of partial nephrectomy (PN) and RN ablation outcomes, with a median follow-up period of three years.
The researchers found that cancer-specific survival rates were 98.8 (PN) and 100 percent (RN) for the procedures at seven years. However, RN brought about a nearly 11 times greater risk of chronic kidney disease at clinically significant levels. For this reason, partial nephrectomy approaches that do not completely remove one of the body’s two kidneys are recommended whenever possible.
Since 2011, Dr. Alan Sadah has practiced urology with Metro Chicago Surgical Oncology in Chicago, Illinois. In this capacity Dr. Alan Sadah welcomes patients in need of nephrostomy tubing.
In a healthy human urinary tract, urine passes from the kidney into the bladder by way of a tube known as the ureter. If the ureter becomes blocked, the lack of proper urinary flow can lead to kidney damage or infected urine, which poses a serious risk to the patient.
A nephrostomy tube can bypass the damaged ureter and channel urine into an external bag. In some cases, however, it may drain the urine directly into the bladder.
A nephrostomy tube is a surgically introduced device that drains urine from the kidney into the bladder or an external bag. The kidney can then function as normal, while simultaneously clearing up any infection that has developed.
The procedure may take place under sedation or general anesthesia, depending on the patient’s needs. Using X-ray or ultrasonic images, a member of medical staff guides thin needle into position. The medical professional then guides a wire through the needle, removes the needle, and passes a thin tube over the wire.
After removing the wire, the medical professional secures the tube in place. If there is an external bag in place, the professional will attach the tubing to the skin and affix the bag. The patient will receive instructions as to how to care for the nephrostomy system.